Blocking IL-10 signalling at the time of immunization does not increase unwanted side effects in mice
Abstract Background Cancer therapeutic vaccine induced cytotoxic T cell (CTL) responses are pivotal for the killing of tumour cells. Blocking interleukin 10 (IL-10) signalling at the time of immunization increases vaccine induced CTL responses and improves prevention of tumour growth in animal model...
Main Authors: | Guoying Ni, Zaowen Liao, Shu Chen, Tianfang Wang, Jianwei Yuan, Xuan Pan, Kate Mounsey, Shelley Cavezza, Xiaosong Liu, Ming Q. Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | BMC Immunology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12865-017-0224-x |
Similar Items
-
Immunotherapy for Visceral Leishmaniasis: Ability of Factors Produced during Anti-leishmania Responses of Skin Test Positive Adults to Inhibit Peripheral Blood Mononuclear Cell Activities Associated with Visceral Leishmaniasis
by: Holaday Bettie J
Published: (1999-01-01) -
The role of IL-10 in the modulation of the immune response in normal conditions and the tumor environment
by: Jagoda Kicielińska, et al.
Published: (2014-06-01) -
The role of IL-10 in the modulation of the immune response in normal conditions and the tumor environment
by: Jagoda Kicielińska, et al.
Published: (2014-06-01) -
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy
by: Ana Victoria Casadesús, et al.
Published: (2020-01-01) -
Etude du développement lymphoïde T à partir des progéniteurs hématopoïétiques CD34+ chez les patients infectés par le VIH-1 et traités par une thérapie antirétrovirale
by: Menkova, Inna
Published: (2016)